News and Press Releases
Sanner achieves EcoVadis Gold status
Bensheim/Germany, November 12, 2025 – Sanner, a leading global manufacturer of healthcare packaging solutions and a contract development and manufacturing organization (CDMO) for medtech products, has achieved the EcoVadis Gold...
Category:
Posted: November 12, 2025
Acuitas Therapeutics to Showcase LNP Delivery Platform at Four Prestigious Conferences in November 2025
29 October 2025 -- British Columbia, Canada -- Acuitas Therapeutics, a global leader in lipid nanoparticle (LNP) delivery systems, today announced its participation in four upcoming conferences in November 2025....
Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: November 11, 2025
Dr William G Kaelin Jr joins IQVIA Board of Directors
North Carolina, US — IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced the appointment of Dr William G Kaelin Jr to its board...
Category:
Posted: November 11, 2025
EpiCypher Launches Fiber-seq Kit to Democratize Single-Molecule Chromatin Mapping
11 November 2025 -- North Carolina, US -- EpiCypher, a leader in chromatin biology and epigenetics, today announced the launch of its CUTANA Fiber-seq Kit and the exclusive licensing of...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: November 11, 2025
uMotif Harnesses AI to Deliver Faster, Higher-Quality Clinical Trials with MotifAI Assistant
Boston, US, and London, UK – November 3, 2025 – uMotif – one of the clinical technology market’s fastest-growing companies – today announced a multi-phase deployment of MotifAI Assistant, its AI-driven automation, across...
Category:
Posted: November 11, 2025
Commit Biologics achieves proof-of-concept for novel Complement Engager platform in non-human primates
Novel approach harnessing the power of the complement system to drive potent cell depletion Single-dose study shows rapid and sustained immune cell depletion in blood and tissues with a very...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: November 11, 2025
New collaborative strategy platform launches to empower biopharma teams to reach peak sales faster and with greater confidence
11 November 2025 -- London, UK -- In a drug development landscape defined by shifting policies, geopolitical uncertainty, and increasing competitive pressure, a new collaborative strategy platform, Nmblr, has launched to empower...
Category: Biotechnology, Drug Discovery, Logistics, Other, Pharmaceutical
Posted: November 11, 2025
Inside information made public: Nanoform Granted European Commercial cGMP Manufacturing License
Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), the medicine performance-enhancing company, today announced that it has received a Commercial cGMP Manufacturing License from FIMEA (Finnish Medicines Agency) for the production...
Category:
Posted: November 11, 2025
Shift Bioscience publishes improved metric calibration framework for robust genetic perturbation modeling using AI Virtual Cells
Cambridge, UK, 11 November 2025: Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to end the morbidity and mortality of aging, today announced the release of...
Category:
Posted: November 11, 2025
Shift Bioscience Ltd The Gurdon Institute Tennis Court Road Cambridge CB2 1QN United Kingdom
Synthego Launches High-Performance Molecular Reagents for Clinical and Molecular Diagnostics
10 November 2025 -- California, US -- Synthego, a leading provider of CRISPR solutions, has announced a strategic expansion of its product offerings with the launch of a new portfolio of...
Category: Biotechnology, Other, Pharmaceutical
Posted: November 10, 2025
ACG wins Red Dot Design Award for Personalised Medicine Concept
ACG, the world’s most integrated provider of solid-dosage solutions, is proud to announce that its Personalised Medicine Concept (PMC) has been awarded the prestigious Red Dot Award for high design...
Category:
Posted: November 6, 2025
Heidelberg Pharma’s Lead ATAC Candidate HDP-101 Shows Progress in Phase I/IIa Trial in Multiple Myeloma
Evidence of clinical activity observed in Cohort 8, including stringent complete remission in two patients from Cohort 8 HDP-101 continues to demonstrate a favorable safety profile with no dose-limiting toxicities...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: November 6, 2025
H&T Presspart acquires majority stake in Plas-Tech Engineering
Düsseldorf, Germany, 4th November 2025 — H&T Presspart, a division of the Heitkamp & Thumann Group, has reached agreement to acquire a majority stake in Plas-Tech Engineering, a privately-owned medical device...
Category:
Posted: November 5, 2025
Presspart Manufacturing Ltd. Whitebirk Industrial Estate Blackburn, Lancashire BB1 5RF, England
Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate
Immune response successfully improved with second generation vaccine candidate4 November 2025 -- Saint-Herblain, France -- Valneva SE, a specialty vaccine company, today announced positive results of its Phase 1 clinical...
Category: BioManufacturing, Biotechnology, Clinical Trials, Drug Delivery, Other, Pharmaceutical
Posted: November 4, 2025
Fast, precise, efficient: The freeze-drying revolution
Holzkirchen, 23 October 2025 – Tempris, the innovation leader in wireless in-process product temperature control for freeze-drying, is delighted to announce that it has been presented with the 2025 ISPE...
Category:
Posted: November 4, 2025
